Arkolith/Insider Trading/EVLO/Form 4

McHale Duncan

Chief Medical OfficerEvelo Biosciences, Inc. (EVLO) · full profile →Form 4 · filed May 10, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$9K
Net Open-Market Flow
-$9K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 8, 2023Sell(S)67K$0.13$9K98K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001694665-23-000054) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML